Annual Cash & Cash Equivalents
$44.37 M
-$16.77 M-27.44%
December 31, 2023
Summary
- As of February 12, 2025, PLSE annual cash & cash equivalents is $44.37 million, with the most recent change of -$16.77 million (-27.44%) on December 31, 2023.
- During the last 3 years, PLSE annual cash & cash equivalents has risen by +$31.90 million (+255.97%).
- PLSE annual cash & cash equivalents is now -27.44% below its all-time high of $61.14 million, reached on December 31, 2022.
Performance
PLSE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$79.03 M
+$52.84 M+201.70%
September 30, 2024
Summary
- As of February 12, 2025, PLSE quarterly cash and cash equivalents is $79.03 million, with the most recent change of +$52.84 million (+201.70%) on September 30, 2024.
- Over the past year, PLSE quarterly cash and cash equivalents has increased by +$44.15 million (+126.55%).
- PLSE quarterly cash and cash equivalents is now at all-time high.
Performance
PLSE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PLSE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.4% | +126.5% |
| 3 y3 years | +256.0% | +176.2% |
| 5 y5 years | -13.2% | +66.6% |
PLSE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.4% | +55.0% | at high | +523.5% |
| 5 y | 5-year | -27.4% | +543.1% | at high | +1045.6% |
| alltime | all time | -27.4% | +2023.7% | at high | +3871.5% |
Pulse Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $79.03 M(+201.7%) |
| Jun 2024 | - | $26.20 M(-24.9%) |
| Mar 2024 | - | $34.88 M(-21.4%) |
| Dec 2023 | $44.37 M(-27.4%) | $44.37 M(-11.9%) |
| Sep 2023 | - | $50.39 M(-14.2%) |
| Jun 2023 | - | $58.75 M(+8.6%) |
| Mar 2023 | - | $54.10 M(-11.5%) |
| Dec 2022 | $61.14 M(+113.7%) | $61.14 M(-11.6%) |
| Sep 2022 | - | $69.16 M(+367.4%) |
| Jun 2022 | - | $14.80 M(+16.7%) |
| Mar 2022 | - | $12.68 M(-55.7%) |
| Dec 2021 | $28.61 M(+129.6%) | $28.61 M(-31.9%) |
| Sep 2021 | - | $41.99 M(-11.5%) |
| Jun 2021 | - | $47.43 M(-20.8%) |
| Mar 2021 | - | $59.88 M(+380.5%) |
| Dec 2020 | $12.46 M | $12.46 M(+76.3%) |
| Sep 2020 | - | $7.07 M(-81.3%) |
| Jun 2020 | - | $37.77 M(+380.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $7.86 M(+14.0%) |
| Dec 2019 | $6.90 M(-86.5%) | $6.90 M(-27.9%) |
| Sep 2019 | - | $9.57 M(-11.2%) |
| Jun 2019 | - | $10.78 M(+26.3%) |
| Mar 2019 | - | $8.54 M(-83.3%) |
| Dec 2018 | $51.10 M(+1409.2%) | $51.10 M(+707.2%) |
| Sep 2018 | - | $6.33 M(-6.8%) |
| Jun 2018 | - | $6.79 M(-36.3%) |
| Mar 2018 | - | $10.67 M(+215.0%) |
| Dec 2017 | $3.39 M(+62.1%) | $3.39 M(-89.6%) |
| Sep 2017 | - | $32.42 M(+1529.3%) |
| Jun 2017 | - | $1.99 M(-27.7%) |
| Mar 2017 | - | $2.75 M(+31.7%) |
| Dec 2016 | $2.09 M(-42.1%) | $2.09 M(-54.9%) |
| Sep 2016 | - | $4.63 M(-77.1%) |
| Jun 2016 | - | $20.21 M(+860.3%) |
| Mar 2016 | - | $2.10 M(-41.6%) |
| Dec 2015 | $3.61 M(-48.5%) | $3.61 M |
| Dec 2014 | $7.01 M | - |
FAQ
- What is Pulse Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pulse Biosciences?
- What is Pulse Biosciences annual cash & cash equivalents year-on-year change?
- What is Pulse Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pulse Biosciences?
- What is Pulse Biosciences quarterly cash and cash equivalents year-on-year change?
What is Pulse Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of PLSE is $44.37 M
What is the all time high annual cash & cash equivalents for Pulse Biosciences?
Pulse Biosciences all-time high annual cash & cash equivalents is $61.14 M
What is Pulse Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, PLSE annual cash & cash equivalents has changed by -$16.77 M (-27.44%)
What is Pulse Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PLSE is $79.03 M
What is the all time high quarterly cash and cash equivalents for Pulse Biosciences?
Pulse Biosciences all-time high quarterly cash and cash equivalents is $79.03 M
What is Pulse Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, PLSE quarterly cash and cash equivalents has changed by +$44.15 M (+126.55%)